IL6 and cancer: Selectively induced expression of the ADAM12L isoform leading to increased expression of pAKT levels. Treatment causes an NF-κB–IL6–dependent inflammatory environment that induces cancer stemness. Treatment increased the number of CSCs and their self-renewing capability in cells with high expression of CDK4